-
AN AI-BASED MODEL EXPLAINER TO SUPPORT ONBOARDING AND KNOWLEDGE TRANSFER FOR EXCEL COST-EFFECTIVENESS MODELS
Feb 25, 2026, 14:42 PM -
A FRAMEWORK FOR INCORPORATING DISTANCE-TO-CARE METRICS IN CANCER OUTCOMES RESEARCH: EXPLORATORY INSIGHTS USING REAL-WORLD DATA FROM A NETWORK OF COMMUNITY PRACTICES
Feb 25, 2026, 14:42 PM -
IMPACT OF COMORBID DEPRESSION ON HEALTH OUTCOMES AMONG ADULTS WITH SICKLE CELL DISEASE IN TEXAS MEDICAID
Feb 25, 2026, 14:42 PM -
COMPARATIVE CARDIOVASCULAR RISK IN U.S. POSTMENOPAUSAL WOMEN STARTING ROMOSOZUMAB VS DENOSUMAB: A HIGH-DIMENSIONAL INVERSE PROBABILITY OF SELECTION WEIGHTING ANALYSIS FOR MISSING CARDIOVASCULAR RISK FACTORS
Feb 25, 2026, 14:42 PM -
MIND THE GAP:EVALUATION OF ARTIFICIAL INTELLIGENCE (AI) ASSISTED EVIDENCE GAP ANALYSIS APPROACHES FOR PCSK-9 INHIBITORS
Feb 25, 2026, 14:42 PM -
THE ANALYTICAL FRAMEWORK OF CLINICAL TRIALS EVALUATING CLINICAL OUTCOMES OF ARTIFICIAL INTELLIGENCE-BASED DIGITAL HEALTH INTERVENTIONS FOR MENTAL HEALTH DISORDERS: A SYSTEMATIC LITERATURE REVIEW
Feb 25, 2026, 14:42 PM -
BURDEN OF ILLNESS: DIRECT AND INDIRECT ECONOMIC COSTS OF MODERATE-TO-SEVERE ATOPIC DERMATITIS IN THE UNITED STATES
Feb 25, 2026, 14:42 PM -
MOST-FAVOURED NATION, LEAST-FAVOURED CONSEQUENCES: GLOBAL RIPPLE EFFECTS OF U.S. PRICING POLICY
Feb 25, 2026, 14:42 PM -
ESTIMATING THE COST-EFFECTIVENESS OF SPARSENTAN RELATIVE TO REAL-WORLD RENIN-ANGIOTENSIN SYSTEMINHIBITION STANDARD OF CARE FOR IMMUNOGLOBULIN A NEPHROPATHY: A PATIENT-LEVEL MICROSIMULATION
Feb 25, 2026, 14:42 PM -
ASSESSING DRIVERS OF PAYER CONTROL IN RARE DISEASE
Feb 25, 2026, 14:42 PM -
ACCELERATING LITERATURE REVIEWS WITH LARGE LANGUAGE MODELS (LLMS): AN EVALUATION OF PERFORMANCE AND EFFICIENCY
Feb 25, 2026, 14:42 PM -
ASSOCIATION BETWEEN INTRA- AND POST-OPERATIVE SURGICAL COMPLICATIONS AND HEALTH ECONOMIC OUTCOMES IN PATIENTS UNDERGOING SLEEVE GASTRECTOMY: A RETROSPECTIVE DATABASE ANALYSIS
Feb 25, 2026, 14:42 PM -
GLOBAL BURDEN OF MULTIPLE SCLEROSIS AND FUTURE PROJECTIONS: EVIDENCE FROM GBD 2023
Feb 25, 2026, 14:42 PM -
VALIDATION OF AN AI-ASSISTED EVIDENCE SYNTHESIS IN HEOR
Feb 25, 2026, 14:42 PM -
REAL-WORLD IMPACT OF PRODUCTIVITY LOSS AND ASSOCIATED COSTS IN ADULTS WITH INFLAMMATORY ARTHRITIS FROM THE RHEUM4U PRECISION HEALTH REGISTRY
Feb 25, 2026, 14:42 PM -
ONCE-WEEKLY REZAFUNGIN AND ICU EFFICIENCY IN INVASIVE CANDIDIASIS: A RESOURCE UTILIZATION ANALYSIS IN THE BRAZILIAN SUPPLEMENTARY HEALTH SYSTEM
Feb 25, 2026, 14:42 PM -
FROM FINANCIAL STRAIN TO FINANCIAL CAPABILITY: OUTCOMES OF A FAMILY CAREGIVER TRAINING PROGRAM IN SEVERE MENTAL ILLNESS
Feb 25, 2026, 14:42 PM -
INCLUSIVE HEALTH RESEARCH IN THE PALM OF YOUR HAND: THE EVIDATION EVERYONE REGISTRY
Feb 25, 2026, 14:42 PM -
A SURVEY OF HEOR LEADERS IN PHARMA ON THE CHANGING US POLICY LANDSCAPE
Feb 25, 2026, 14:42 PM -
HEALTH-ECONOMIC VALUE OF A NOVEL ANASTOMOSIS PROTECTION DEVICE AFTER COLORECTAL RESECTION: AN ANALYSIS BASED ON THE SAFE-2025 STUDY AND U.S. CLAIMS DATA
Feb 25, 2026, 14:42 PM
